1 |
Di Marco A, Brown PF, Bradley J, Nucifora G, Anguera I, Miller CA, Schmitt M. Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2023;24:512-21. [PMID: 35877070 DOI: 10.1093/ehjci/jeac142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Régis C, Benali K, Rouzet F. FDG PET/CT Imaging of Sarcoidosis. Semin Nucl Med 2023;53:258-72. [PMID: 36870707 DOI: 10.1053/j.semnuclmed.2022.08.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Hatipoglu S, Gardezi SKM, Azzu A, Baksi J, Alpendurada F, Izgi C, Khattar R, Kouranos V, Wells AU, Sharma R, Wechalekar K, Pennell DJ, Mohiaddin R. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias. Heart 2023:heartjnl-2022-321974. [PMID: 36627181 DOI: 10.1136/heartjnl-2022-321974] [Reference Citation Analysis]
|
4 |
Chareonthaitawee P, Gutberlet M. Clinical Utilization of Multimodality Imaging for Myocarditis and Cardiac Sarcoidosis. Circ Cardiovasc Imaging 2023;16:e014091. [PMID: 36649452 DOI: 10.1161/CIRCIMAGING.122.014091] [Reference Citation Analysis]
|
5 |
Monroy-Gonzalez AG, Erba PA, Slart RHJA. (68)Ga-DOTATATE PET/CT for assessment of cardiac sarcoidosis: hidden opportunities? J Nucl Cardiol 2022. [PMID: 36565430 DOI: 10.1007/s12350-022-03168-1] [Reference Citation Analysis]
|
6 |
Slivnick JA, Wali E, Patel AR. Imaging in Cardiac Sarcoidosis: Complementary Role of Cardiac Magnetic Resonance and Cardiac Positron Emission Tomography. Curr Cardiovasc Imaging Rep 2022. [DOI: 10.1007/s12410-022-09571-z] [Reference Citation Analysis]
|
7 |
Tzimas G, Ryan DT, Murphy DJ, Leipsic JA, Dodd JD. Cardiovascular CT, MRI, and PET/CT in 2021: Review of Key Articles. Radiology 2022. [DOI: 10.1148/radiol.221181] [Reference Citation Analysis]
|
8 |
Solmaz H, Ozdogan O. Left atrial phasic volumes and functions changes in asymptomatic patients with sarcoidosis: evaluation by three-dimensional echocardiography. Acta Cardiol 2022;77:782-90. [PMID: 36326190 DOI: 10.1080/00015385.2022.2119668] [Reference Citation Analysis]
|
9 |
Kusmirek JE, Mcmillan AB. Cardiac PET/MR. Advances in Clinical Radiology 2022;4:87-109. [DOI: 10.1016/j.yacr.2022.04.008] [Reference Citation Analysis]
|
10 |
Vereckei A, Katona G, Révész K, Vágó H, Müller V, Nagy B, Nagy P, Sepp R, Suvarna K. Cardiac sarcoidosis completely mimicking biventricular arrhythmogenic cardiomyopathy. ESC Heart Fail 2022;9:4304-14. [PMID: 36045019 DOI: 10.1002/ehf2.14123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
11 |
Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, Sade LE, Ajmone-Marsan N, Seferovic P, Donal E, Nurmohamed M, Cerinic MM, Sfikakis P, Kitas G, Schwitter J, Lima JAC, Dawson D, Dweck M, Haugaa KH, Keenan N, Moon J, Stankovic I, Donal E, Cosyns B. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2022;23:e308-22. [PMID: 35808990 DOI: 10.1093/ehjci/jeac134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|
12 |
Albakaa NK, Sato K, Iida N, Yamamoto M, Machino-Ohtsuka T, Ishizu T, Ieda M. Association between right ventricular longitudinal strain and cardiovascular events in patients with cardiac sarcoidosis. J Cardiol 2022:S0914-5087(22)00193-9. [PMID: 35981941 DOI: 10.1016/j.jjcc.2022.07.015] [Reference Citation Analysis]
|
13 |
Aitken M, Chan MV, Urzua Fresno C, Farrell A, Islam N, McInnes MDF, Iwanochko M, Balter M, Moayedi Y, Thavendiranathan P, Metser U, Veit-Haibach P, Hanneman K. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology 2022;:213170. [PMID: 35579526 DOI: 10.1148/radiol.213170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
14 |
Desbois A, Charpentier E, Chapelon C, Bergeret S, Badenco N, Redheuil A, Cacoub P, Saadoun D. Sarcoïdose cardiaque : stratégies diagnostiques et thérapeutiques actuelles. La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2021.08.018] [Reference Citation Analysis]
|
15 |
Jahandideh A, Ståhle M, Virta J, Li XG, Liljenbäck H, Moisio O, Knuuti J, Roivainen A, Saraste A. Evaluation of [68Ga]Ga-NODAGA-RGD for PET Imaging of Rat Autoimmune Myocarditis. Front Med (Lausanne) 2021;8:783596. [PMID: 34977085 DOI: 10.3389/fmed.2021.783596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
16 |
Martineau P, Galarneau MP, Birnie D. Cardiac Sarcoidosis. FDG-PET/CT and PET/MR in Cardiovascular Diseases 2022. [DOI: 10.1007/978-3-031-09807-9_5] [Reference Citation Analysis]
|
17 |
Phelan D, Thomas J. Evaluation and monitoring of patients with cardiomyopathies (including myocardial infiltration). ASE's Comprehensive Strain Imaging 2022. [DOI: 10.1016/b978-0-323-75947-2.00013-1] [Reference Citation Analysis]
|
18 |
Murphy DJ, Dorbala S. Myocardial Inflammation: Focus on Cardiac Sarcoidosis. Hybrid Cardiac Imaging 2022. [DOI: 10.1007/978-3-030-83167-7_10] [Reference Citation Analysis]
|
19 |
Kysperska K, Kuchynka P, Palecek T. Cardiac sarcoidosis: from diagnosis to treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:347-59. [PMID: 34671170 DOI: 10.5507/bp.2021.057] [Reference Citation Analysis]
|
20 |
Fernández BD, Campos AG, González-juanatey MPDYJ. Myocarditis. Medicine - Programa de Formación Médica Continuada Acreditado 2021;13:2423-2432. [DOI: 10.1016/j.med.2021.09.019] [Reference Citation Analysis]
|
21 |
Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C, Chrispin J, Sharp M, Kasper EK, Chen ES, Blankstein R, Cooper LT, Joyce E, Sheikh FH. Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review. J Card Fail 2021:S1071-9164(21)00264-5. [PMID: 34260889 DOI: 10.1016/j.cardfail.2021.06.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
22 |
Vidula MK, Bravo PE. Multimodality imaging for the diagnosis of infiltrative cardiomyopathies. Heart 2021:heartjnl-2020-318001. [PMID: 34039679 DOI: 10.1136/heartjnl-2020-318001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
23 |
Gimelli A, Ernst S, Liga R. Multi-Modality Imaging for the Identification of Arrhythmogenic Substrates Prior to Electrophysiology Studies. Front Cardiovasc Med 2021;8:640087. [PMID: 33996938 DOI: 10.3389/fcvm.2021.640087] [Reference Citation Analysis]
|
24 |
Mandoli GE, De Carli G, Pastore MC, Cameli P, Contorni F, D'Alessandro M, Bargagli E, Mondillo S, Cameli M. Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication. J Intern Med 2021;289:440-9. [PMID: 32996153 DOI: 10.1111/joim.13179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
25 |
Bakker ALM, Mathijssen H, Azzahhafi J, Swaans MJ, Veltkamp M, Keijsers RGM, Akdim F, Post MC, Grutters JC. Effectiveness and safety of infliximab in cardiac Sarcoidosis. Int J Cardiol 2021;330:179-85. [PMID: 33582196 DOI: 10.1016/j.ijcard.2021.02.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
26 |
Chowdhary A, Garg P, Das A, Nazir MS, Plein S. Cardiovascular magnetic resonance imaging: emerging techniques and applications. Heart 2021;107:697-704. [PMID: 33402364 DOI: 10.1136/heartjnl-2019-315669] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
27 |
Bourgade R, Piriou N, Bressollette-Bodin C, Loussouarn D, Toquet C. [Inflammatory cardiomyopathies: Diagnosis, correlations with imaging, interest of myocardial biopsy and place of molecular biology]. Ann Pathol 2021;41:71-84. [PMID: 33388193 DOI: 10.1016/j.annpat.2020.10.007] [Reference Citation Analysis]
|
28 |
Lemay S, Massot M, Philippon F, Belzile D, Turgeon PY, Beaudoin J, Laliberté C, Fortin S, Dion G, Milot J, Trottier M, Gosselin J, Charbonneau É, Birnie DH, Sénéchal M. Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review. CJC Open 2021;3:532-48. [PMID: 34027358 DOI: 10.1016/j.cjco.2020.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
29 |
Leiner T, Bogaert J, Friedrich MG, Mohiaddin R, Muthurangu V, Myerson S, Powell AJ, Raman SV, Pennell DJ. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2020;22:76. [PMID: 33161900 DOI: 10.1186/s12968-020-00682-4] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 32.3] [Reference Citation Analysis]
|
30 |
Masri SC, Bellumkonda L. Sarcoid Heart Disease: an Update on Diagnosis and Management. Curr Cardiol Rep 2020;22:177. [PMID: 33119794 DOI: 10.1007/s11886-020-01429-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
31 |
Piriou N, Bruneval P. Cardiac sarcoidosis: A multimodal approach to reach the diagnosis. Int J Cardiol 2021;323:264-6. [PMID: 33096145 DOI: 10.1016/j.ijcard.2020.10.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
32 |
Miller RJH, Cadet S, Pournazari P, Pope A, Kransdorf E, Hamilton MA, Patel J, Hayes S, Friedman J, Thomson L, Tamarappoo B, Berman DS, Slomka PJ. Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis. J Nucl Cardiol 2020. [PMID: 32462631 DOI: 10.1007/s12350-020-02201-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
33 |
Roth D, Kadoglou N, Leeflang M, Spijker R, Herkner H, Trivella M. Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis. Diagn Progn Res 2020;4:5. [PMID: 32399494 DOI: 10.1186/s41512-020-00073-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
34 |
Kalshetty A, Basu S. PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises. PET Clin 2020;15:163-73. [PMID: 32145887 DOI: 10.1016/j.cpet.2019.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
35 |
Rischpler C, Siebermair J, Kessler L, Quick HH, Umutlu L, Rassaf T, Antoch G, Herrmann K, Nensa F. Cardiac PET/MRI: Current Clinical Status and Future Perspectives. Semin Nucl Med 2020;50:260-9. [PMID: 32284112 DOI: 10.1053/j.semnuclmed.2020.02.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
36 |
Lee E, Ibrahim EH, Parwani P, Bhave N, Stojanovska J. Practical Guide to Evaluating Myocardial Disease by Cardiac MRI. AJR Am J Roentgenol 2020;214:546-56. [PMID: 31967503 DOI: 10.2214/AJR.19.22076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
37 |
Travin MI. Radionuclide Imaging for Cardiac Sarcoidosis: Much Potential Benefit, but Still Much to Do. Annals of Nuclear Cardiology 2020;6:53-60. [DOI: 10.17996/anc.20-00115] [Reference Citation Analysis]
|
38 |
Serova MV, Poltavskaya MG, Garmash YY, Ivanova DA, Pershina ES, Zyuzya Y, Sazonova YS, Lukin MY, Samoilenko IV, Uyanaeva MA, Syrkin AL, Melkonyan GG. Complete atrioventricular block as a clinical manifestation of cardiac sarcoidosis. Russ J Cardiol 2019. [DOI: 10.15829/1560-4071-2019-11-63-68] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
39 |
Nhan P, Ederhy S, Soulat-Dufour L, Ancedy Y, Chauvet-Droit M, Adavane-Scheublé S, Ben Said R, Lajus M, Boccara F, Cohen A. [Cardiovascular imaging in heart failure]. Presse Med 2019;48:1406-15. [PMID: 31761606 DOI: 10.1016/j.lpm.2019.09.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
40 |
Mankad P, Mitchell B, Birnie D, Kron J. Cardiac Sarcoidosis. Curr Cardiol Rep 2019;21:152. [PMID: 31768666 DOI: 10.1007/s11886-019-1238-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
41 |
Sollini M, Bandera F, Kirienko M. Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018. Eur J Nucl Med Mol Imaging 2019;46:2737-45. [PMID: 31690962 DOI: 10.1007/s00259-019-04531-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
42 |
Ederhy S, Mansencal N, Réant P, Piriou N, Barone-Rochette G. Role of multimodality imaging in the diagnosis and management of cardiomyopathies. Arch Cardiovasc Dis 2019;112:615-29. [PMID: 31607558 DOI: 10.1016/j.acvd.2019.07.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
43 |
Bière L, Piriou N, Ernande L, Rouzet F, Lairez O. Imaging of myocarditis and inflammatory cardiomyopathies. Arch Cardiovasc Dis 2019;112:630-41. [PMID: 31494082 DOI: 10.1016/j.acvd.2019.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
|
44 |
Barberato SH, Romano MMD, Beck ALS, Rodrigues ACT, Almeida ALC, Assunção BMBL, Gripp EA, Guimarães Filho FV, Abensur H, Castillo JMD, Miglioranza MH, Vieira MLC, Barros MVL, Nunes MDCP, Otto MEB, Hortegal RA, Barretto RBM, Campos TH, Siqueira VN, Morhy SS. Position Statement on Indications of Echocardiography in Adults - 2019. Arq Bras Cardiol 2019;113:135-81. [PMID: 31411301 DOI: 10.5935/abc.20190129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
45 |
Ramirez R, Trivieri M, Fayad ZA, Ahmadi A, Narula J, Argulian E. Advanced Imaging in Cardiac Sarcoidosis. J Nucl Med 2019;60:892-8. [PMID: 31171594 DOI: 10.2967/jnumed.119.228130] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
|
46 |
West SG. Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations. Curr Opin Rheumatol 2018;30:243-8. [PMID: 29389828 DOI: 10.1097/BOR.0000000000000489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
47 |
Nazir MS, Ismail TF, Reyes E, Chiribiri A, Kaufmann PA, Plein S. Hybrid positron emission tomography-magnetic resonance of the heart: current state of the art and future applications. Eur Heart J Cardiovasc Imaging 2018;19:962-74. [PMID: 30010838 DOI: 10.1093/ehjci/jey090] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
48 |
Ebert M, Richter S, Dinov B, Zeppenfeld K, Hindricks G. Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy. Heart Rhythm 2019;16:624-31. [DOI: 10.1016/j.hrthm.2018.10.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
49 |
Imazio M, Andriani M, Lobetti Bodoni L, Gaita F. Cardiomyopathies. Learning Cardiac Magnetic Resonance 2019. [DOI: 10.1007/978-3-030-11608-8_5] [Reference Citation Analysis]
|
50 |
Bravo PE, Singh A, Di Carli MF, Blankstein R. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2019;26:188-99. [PMID: 30390241 DOI: 10.1007/s12350-018-01488-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
|
51 |
Edvardsen T, Haugaa KH, Gerber BL, Maurovich-Horvat P, Donal E, Maurer G, Popescu BA. The year 2017 in the European Heart Journal-Cardiovascular Imaging: Part II. Eur Heart J Cardiovasc Imaging 2018;19:1222-9. [PMID: 30084988 DOI: 10.1093/ehjci/jey110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
52 |
Sollini M, Berchiolli R, Kirienko M, Rossi A, Glaudemans AWJM, Slart R, Erba PA. PET/MRI in Infection and Inflammation. Semin Nucl Med 2018;48:225-41. [PMID: 29626940 DOI: 10.1053/j.semnuclmed.2018.02.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
|
53 |
Kurmann R, Mankad SV, Mankad R. Echocardiography in Sarcoidosis. Curr Cardiol Rep 2018;20:118. [PMID: 30259211 DOI: 10.1007/s11886-018-1065-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
54 |
Nordenswan H, Lehtonen J, Ekström K, Kandolin R, Simonen P, Mäyränpää M, Vihinen T, Miettinen H, Kaikkonen K, Haataja P, Kerola T, Rissanen TT, Kokkonen J, Alatalo A, Pietilä-effati P, Utriainen S, Kupari M. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block. Circ: Arrhythmia and Electrophysiology 2018;11. [DOI: 10.1161/circep.117.006145] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
|
55 |
Signore A, Lazzeri E, Glaudemans AWJM. Infection and inflammation imaging standardization: the EANM guidelines. Clin Transl Imaging 2018;6:253-5. [DOI: 10.1007/s40336-018-0288-5] [Reference Citation Analysis]
|
56 |
Saab R, Bhambhvani P, Iskandrian AE, Hage FG. A case of longitudinal care of a patient with cardiac sarcoidosis. J Nucl Cardiol 2018;25:443-56. [PMID: 29423905 DOI: 10.1007/s12350-018-1217-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
57 |
Nkoulou R, Zaidi H. Does simplified quantitative analysis of 18F-FDG PET in cardiac inflammatory disease work? J Nucl Cardiol 2019;26:919-21. [PMID: 29344921 DOI: 10.1007/s12350-017-1179-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|